Vaccination: a history of vaccines (HHS) HE 20.30/A: V 13/CD
The status of research into vaccine safety and autism: hearing (U.S. Congress) Y 4.G 74/7:V 13/6
The continuing oversight of the National Vaccine Injury Compensation Program: hearing (U.S. Congress) Y 4.G 74/7:V 13/7
The National Vaccine Injury Program: is it working as Congress intended?: hearing (U.S. Congress) Y 4.G 74/7:V 13/5
Compensating vaccine injuries: are reforms needed?: hearing (U.S. Congress) Y 4.G 74/7:V 13/3
Use of expert testimony, specialized decision makers, and case-management innovations in the National Vaccine Injury Compensation Program (Federal Judicial Center) JU 13.2:T 28
Compensation for vaccine-related injuries: a technical memorandum (U.S. Congress / OTA) Y 3.T 22/2:11 V 13
The reemergence of vaccine-preventable diseases: exploring the public health successes and challenge: hearing Y 4.L 11/4:S.HRG.114-554
Vaccine characteristics: epidemiology, prevention, and control of diseases preventable through immunization (HHS) HE 20.7002:V 13/2
Immunobiologic agents and drugs available from the Centers for Disease Control: descriptions, recommendations, adverse reactions, and serologic response (HHS) HE 20.7008:Im 6/3